Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-messenger RNA (miRNA-mRNA) interaction is a fundamental regulatory mechanism in which small non-coding RNAs (miRNAs) bind to target messenger RNAs (mRNAs), leading to translational repression or mRNA degradation. This process plays a crucial role in regulating gene expression across a wide range of biological processes and diseases. The interaction is mediated by the RNA-induced silencing complex (RISC), which contains an Argonaute (AGO) protein and the miRNA. The miRNA guides the RISC to its target mRNA through base-pairing interactions, primarily within the 3' untranslated region (3' UTR). Perfect complementarity leads to mRNA cleavage (primarily in plants), while imperfect complementarity results in translational repression or mRNA decay (primarily in animals). The complexity of this interaction is underscored by the fact that a single miRNA can target multiple mRNAs, and a single mRNA can be regulated by multiple miRNAs. Dysregulation of miRNA-mRNA interactions has been implicated in various diseases, making it an area of intense research and potential therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-messenger RNA Interaction (miRNA-mRNA Interaction).